The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 01, 2019

Filed:

May. 06, 2016
Applicant:

Samsung Electronics Co., Ltd., Gyeonggi-do, KR;

Inventors:

Hyoung-seon Choi, Seoul, KR;

Chul-ho Cho, Gyeonggi-do, KR;

Seong-je Cho, Gyeonggi-do, KR;

Kwang-bok Kim, Incheon, KR;

Seung-min Lee, Seoul, KR;

Sun-tae Jung, Gyeonggi-do, KR;

Jae-geol Cho, Gyeonggi-do, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 5/145 (2006.01); A61B 5/11 (2006.01); G06F 19/00 (2018.01); A61B 5/00 (2006.01); A61B 5/0205 (2006.01); A61B 5/024 (2006.01);
U.S. Cl.
CPC ...
A61B 5/14532 (2013.01); A61B 5/02055 (2013.01); A61B 5/02438 (2013.01); A61B 5/11 (2013.01); A61B 5/14514 (2013.01); A61B 5/14517 (2013.01); A61B 5/14546 (2013.01); A61B 5/4809 (2013.01); A61B 5/681 (2013.01); A61B 5/6833 (2013.01); A61B 5/7275 (2013.01); A61B 5/7282 (2013.01); A61B 5/749 (2013.01); A61B 5/7435 (2013.01); A61B 5/7465 (2013.01); G06F 19/00 (2013.01); A61B 2503/10 (2013.01); A61B 2562/0219 (2013.01); A61B 2562/0223 (2013.01);
Abstract

Methods and apparatuses for blood glucose measurement are provided. A first glucose concentration in a body fluid of a user is detected based on a first measurement interval. A first blood glucose level of the user is determined based on the first glucose concentration. A glucose concentration measurement interval is changed from the first measurement interval to a second measurement interval according to an occurrence of an event. A second glucose concentration in the body fluid is detected based on the second measurement interval. A second blood glucose level of the user is determined based on the second glucose concentration.


Find Patent Forward Citations

Loading…